Lv21
140 积分 2024-09-01 加入
Unveiling the Future of Breast Cancer Therapy: Cutting-Edge Antibody-Drug Conjugate Strategies and Clinical Outcomes
17分钟前
已完结
Management of hormone receptor-positive, HER2-negative early breast cancer
26分钟前
已完结
Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
32分钟前
已完结
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era
43分钟前
已完结
Adjuvant and neoadjuvant therapy with or without CDK4/6 inhibitors in HR+/HER2- early breast cancer: a systematic review and meta-analysis
47分钟前
已完结
What Is the Role of Neoadjuvant Endocrine Therapy for Breast Cancer?
50分钟前
已完结
A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
56分钟前
已完结
Combination of autophagy inhibitors with high-dose CDK4/6 inhibitors offers new hope for advanced HR+/HER2− breast cancer
1小时前
求助中
Abemaciclib: A Review in Early Breast Cancer with a High Risk of Recurrence
1小时前
已完结
Computational Optimization and In Silico Analysis for the Discovery of New HER2 and CDK4/6 Drug Candidates for Breast Cancer
1小时前
求助中
皖公网安备34019202002308
